1,2-dichloroethane affects expression EXP 6480464 ethylene dichloride affects the expression of CDK14 mRNA CTD PMID:28960355 1,3-dinitrobenzene decreases expression ISO RGD:1305544 6480464 3-dinitrobenzene results in decreased expression of CDK14 mRNA CTD PMID:21983209 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of CDK14 mRNA CTD PMID:17942748 17alpha-ethynylestradiol multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CDK14 mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO RGD:1313632 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of CDK14 mRNA CTD PMID:30165855 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CDK14 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1305544 6480464 Tetrachlorodibenzodioxin results in decreased expression of CDK14 mRNA CTD PMID:32109520 , PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of CDK14 mRNA CTD PMID:24680724 2,3,7,8-Tetrachlorodibenzofuran decreases expression ISO RGD:1305544 6480464 2 more ... CTD PMID:32109520 3,4-methylenedioxymethamphetamine increases expression EXP 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of CDK14 mRNA CTD PMID:20188158 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:1305544 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of CDK14 mRNA CTD PMID:30071829 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1313632 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of CDK14 mRNA CTD PMID:28628672 3-Nitrobenzanthrone decreases expression ISO RGD:1313632 6480464 3-nitrobenzanthrone results in decreased expression of CDK14 mRNA CTD PMID:34036453 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1313632 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of CDK14 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol affects methylation EXP 6480464 bis(4-hydroxyphenyl)sulfone affects the methylation of CDK14 gene CTD PMID:31683443 4-hydroxyphenyl retinamide decreases expression EXP 6480464 Fenretinide results in decreased expression of CDK14 mRNA CTD PMID:28973697 4-nitrophenol increases expression EXP 6480464 4-nitrophenol results in increased expression of CDK14 mRNA CTD PMID:34673133 6-propyl-2-thiouracil decreases expression ISO RGD:1305544 6480464 Propylthiouracil results in decreased expression of CDK14 mRNA CTD PMID:22504374 acrylamide decreases expression ISO RGD:1305544 6480464 Acrylamide results in decreased expression of CDK14 mRNA CTD PMID:28959563 aflatoxin B1 affects expression ISO RGD:1313632 6480464 Aflatoxin B1 affects the expression of CDK14 protein CTD PMID:20106945 aflatoxin B1 decreases methylation ISO RGD:1313632 6480464 Aflatoxin B1 results in decreased methylation of CDK14 gene CTD PMID:27153756 aflatoxin B1 decreases expression ISO RGD:1313632 6480464 Aflatoxin B1 results in decreased expression of CDK14 mRNA CTD PMID:22100608 aldrin increases expression EXP 6480464 Aldrin results in increased expression of CDK14 mRNA CTD PMID:18579281 all-trans-retinoic acid decreases expression ISO RGD:1313632 6480464 Tretinoin results in decreased expression of CDK14 mRNA CTD PMID:21934132 all-trans-retinoic acid increases expression ISO RGD:1313632 6480464 Tretinoin results in increased expression of CDK14 mRNA CTD PMID:33167477 antirheumatic drug decreases expression ISO RGD:1313632 6480464 Antirheumatic Agents results in decreased expression of CDK14 mRNA CTD PMID:24449571 aristolochic acid A decreases expression ISO RGD:1313632 6480464 aristolochic acid I results in decreased expression of CDK14 mRNA CTD PMID:33212167 arsenite(3-) multiple interactions EXP 6480464 [arsenite co-treated with Benzo(a)pyrene] results in decreased expression of CDK14 mRNA CTD PMID:15894712 arsenite(3-) multiple interactions ISO RGD:1313632 6480464 arsenite inhibits the reaction [G3BP1 protein binds to CDK14 mRNA] CTD PMID:32406909 arsenite(3-) increases expression EXP 6480464 arsenite results in increased expression of CDK14 mRNA CTD PMID:15894712 atrazine affects methylation ISO RGD:1305544 6480464 Atrazine affects the methylation of CDK14 gene CTD PMID:28931070 benzo[a]pyrene multiple interactions EXP 6480464 [arsenite co-treated with Benzo(a)pyrene] results in decreased expression of CDK14 mRNA CTD PMID:15894712 benzo[a]pyrene affects methylation ISO RGD:1313632 6480464 Benzo(a)pyrene affects the methylation of CDK14 3' UTR more ... CTD PMID:27901495 , PMID:30157460 benzo[a]pyrene increases methylation ISO RGD:1313632 6480464 Benzo(a)pyrene results in increased methylation of CDK14 exon CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:1313632 6480464 Benzo(a)pyrene results in decreased expression of CDK14 mRNA CTD PMID:20064835 more ... benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of CDK14 mRNA CTD PMID:15894712 , PMID:21569818 benzo[e]pyrene affects methylation ISO RGD:1313632 6480464 benzo(e)pyrene affects the methylation of CDK14 intron CTD PMID:30157460 bis(2-chloroethyl) sulfide affects expression ISO RGD:1305544 6480464 Mustard Gas affects the expression of CDK14 mRNA CTD PMID:15651846 bisphenol A decreases expression ISO RGD:1305544 6480464 bisphenol A results in decreased expression of CDK14 mRNA CTD PMID:25181051 more ... bisphenol A affects methylation ISO RGD:1313632 6480464 bisphenol A affects the methylation of CDK14 gene CTD PMID:31601247 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CDK14 mRNA CTD PMID:35598803 C60 fullerene decreases expression ISO RGD:1305544 6480464 fullerene C60 results in decreased expression of CDK14 mRNA CTD PMID:19167457 cadmium dichloride decreases expression ISO RGD:1305544 6480464 Cadmium Chloride results in decreased expression of CDK14 mRNA CTD PMID:33453195 carbon nanotube decreases expression EXP 6480464 Nanotubes, Carbon analog results in decreased expression of CDK14 mRNA CTD PMID:25554681 CGP 52608 multiple interactions ISO RGD:1313632 6480464 CGP 52608 promotes the reaction [RORA protein binds to CDK14 gene] CTD PMID:28238834 choline multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CDK14 mRNA CTD PMID:20938992 chrysene decreases expression EXP 6480464 chrysene results in decreased expression of CDK14 mRNA CTD PMID:26377693 cisplatin decreases expression ISO RGD:1305544 6480464 Cisplatin results in decreased expression of CDK14 mRNA CTD PMID:22023808 cisplatin multiple interactions ISO RGD:1313632 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of CDK14 mRNA CTD PMID:27392435 coumarin increases phosphorylation ISO RGD:1313632 6480464 coumarin results in increased phosphorylation of CDK14 protein CTD PMID:35688186 crocidolite asbestos decreases expression EXP 6480464 Asbestos, Crocidolite results in decreased expression of CDK14 mRNA CTD PMID:29279043 cyclosporin A decreases expression ISO RGD:1313632 6480464 Cyclosporine results in decreased expression of CDK14 mRNA CTD PMID:22147139 , PMID:27989131 cyclosporin A decreases methylation ISO RGD:1313632 6480464 Cyclosporine results in decreased methylation of CDK14 promoter CTD PMID:27989131 decabromodiphenyl ether increases expression ISO RGD:1305544 6480464 decabromobiphenyl ether results in increased expression of CDK14 mRNA CTD PMID:23914054 dexamethasone multiple interactions ISO RGD:1313632 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of CDK14 mRNA CTD PMID:28628672 dioxygen multiple interactions EXP 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CDK14 mRNA CTD PMID:30529165 endosulfan decreases expression ISO RGD:1305544 6480464 Endosulfan results in decreased expression of CDK14 mRNA CTD PMID:29391264 epoxiconazole increases expression EXP 6480464 epoxiconazole results in increased expression of CDK14 mRNA CTD PMID:35436446 ethanol multiple interactions EXP 6480464 Ethanol affects the expression of and affects the splicing of CDK14 mRNA CTD PMID:30319688 folic acid multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CDK14 mRNA CTD PMID:20938992 formaldehyde decreases expression ISO RGD:1313632 6480464 Formaldehyde results in decreased expression of CDK14 mRNA CTD PMID:23649840 geldanamycin increases expression ISO RGD:1313632 6480464 geldanamycin results in increased expression of CDK14 mRNA CTD PMID:26705709 gentamycin increases expression ISO RGD:1305544 6480464 Gentamicins results in increased expression of CDK14 mRNA CTD PMID:33387578 indometacin multiple interactions ISO RGD:1313632 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of CDK14 mRNA CTD PMID:28628672 ketamine decreases expression ISO RGD:1305544 6480464 Ketamine results in decreased expression of CDK14 mRNA CTD PMID:20080153 L-methionine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CDK14 mRNA CTD PMID:20938992 mercury dichloride decreases expression ISO RGD:1313632 6480464 Mercuric Chloride results in decreased expression of CDK14 mRNA CTD PMID:27188386 mercury dichloride increases expression ISO RGD:1313632 6480464 Mercuric Chloride results in increased expression of CDK14 mRNA CTD PMID:27188386 methapyrilene affects methylation ISO RGD:1313632 6480464 Methapyrilene affects the methylation of CDK14 intron CTD PMID:30157460 methimazole decreases expression ISO RGD:1305544 6480464 Methimazole results in decreased expression of CDK14 mRNA CTD PMID:22504374 N,N-diethyl-m-toluamide multiple interactions ISO RGD:1305544 6480464 [Permethrin co-treated with DEET] results in increased methylation of CDK14 gene CTD PMID:33148267 nickel sulfate decreases expression ISO RGD:1313632 6480464 nickel sulfate results in decreased expression of CDK14 mRNA CTD PMID:22714537 O-methyleugenol decreases expression ISO RGD:1313632 6480464 methyleugenol results in decreased expression of CDK14 mRNA CTD PMID:32234424 ochratoxin A decreases acetylation ISO RGD:1313632 6480464 ochratoxin A results in decreased acetylation of CDK14 promoter CTD PMID:29098329 ochratoxin A decreases expression ISO RGD:1313632 6480464 ochratoxin A results in decreased expression of CDK14 mRNA CTD PMID:29098329 ochratoxin A multiple interactions ISO RGD:1313632 6480464 [ochratoxin A results in decreased acetylation of CDK14 promoter] which results in decreased expression of CDK14 mRNA CTD PMID:29098329 oxaliplatin multiple interactions ISO RGD:1305544 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of CDK14 mRNA CTD PMID:25729387 paracetamol decreases expression ISO RGD:1313632 6480464 Acetaminophen results in decreased expression of CDK14 mRNA CTD PMID:21420995 permethrin multiple interactions ISO RGD:1305544 6480464 [Permethrin co-treated with DEET] results in increased methylation of CDK14 gene CTD PMID:33148267 potassium chromate decreases expression ISO RGD:1313632 6480464 potassium chromate(VI) results in decreased expression of CDK14 mRNA CTD PMID:22714537 sodium arsenite decreases expression ISO RGD:1313632 6480464 sodium arsenite results in decreased expression of CDK14 mRNA CTD PMID:34032870 sodium dichromate affects expression ISO RGD:1305544 6480464 sodium bichromate affects the expression of CDK14 mRNA CTD PMID:22110744 temozolomide decreases expression ISO RGD:1313632 6480464 Temozolomide results in decreased expression of CDK14 mRNA CTD PMID:31758290 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of CDK14 mRNA CTD PMID:17484886 thimerosal affects expression ISO RGD:1313632 6480464 Thimerosal affects the expression of CDK14 mRNA CTD PMID:27188386 topotecan multiple interactions ISO RGD:1305544 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of CDK14 mRNA CTD PMID:25729387 torcetrapib increases expression ISO RGD:1313632 6480464 torcetrapib results in increased expression of CDK14 mRNA CTD PMID:23228038 trichostatin A decreases expression ISO RGD:1313632 6480464 trichostatin A results in decreased expression of CDK14 mRNA CTD PMID:26272509 triphenyl phosphate decreases expression ISO RGD:1305544 6480464 triphenyl phosphate results in decreased expression of CDK14 mRNA CTD PMID:30589522 triptonide decreases expression EXP 6480464 triptonide results in decreased expression of CDK14 mRNA CTD PMID:33045310 valproic acid decreases methylation ISO RGD:1313632 6480464 Valproic Acid results in decreased methylation of CDK14 gene CTD PMID:29154799 valproic acid affects expression ISO RGD:1313632 6480464 Valproic Acid affects the expression of CDK14 mRNA CTD PMID:25979313 valproic acid decreases expression ISO RGD:1313632 6480464 Valproic Acid results in decreased expression of CDK14 mRNA CTD PMID:26272509 vorinostat decreases expression ISO RGD:1313632 6480464 vorinostat results in decreased expression of CDK14 mRNA CTD PMID:27188386 WIN 55212-2 increases expression EXP 6480464 (3R)-((2 more ... CTD PMID:12237329
